JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) (“Teva”) announced today that it has closed the previously announced offering, by its special purpose finance subsidiaries, of a debt offering in three tranches:
